Patient selection for transcatheter aortic valve replacement: how to choose an appropriate candidate by Jurin, Ivana et al.
2021;16(9-10):306.
5. kongres Radne skupine za bolesti srčanih zalistaka Hrvatskoga kardiološkog društva s međunarodnim sudjelovanjem 
5th Congress of the Working Group on Valvular Diseases of the Croatian Cardiac Society with international participation
September 2-4, 2021, Zagreb, Croatia
Patient selection for transcatheter aortic valve replacement: 
how to choose an appropriate candidate 








University Hospital Dubrava, 
Zagreb, Croatia
KEYWORDS: transcatheter aortic valve implantation, aortic stenosis, patient selection, risk.
CITATION: Cardiol Croat. 2021;16(9-10):306. | https://doi.org/10.15836/ccar2021.306
*ADDRESS fOR CORRESPONDENCE: Ivana Jurin, Klinička bolnica Dubrava, Avenija Gojka Šuška 6, HR-10000 
Zagreb, Croatia. / Phone: +385-95-559-387 / E-mail: ivanajurin1912@gmail.com
ORCID: Ivana Jurin, https://orcid.org/0000-0002-2637-9691 • Tomislav Šipić, https://orcid.org/0000-0001-8652-4523 
Daniel Unić, https://orcid.org/0000-0003-2740-4067 • Igor Rudež, https://orcid.org/0000-0002-7735-6721 





Transcatheter aortic valve implantation (TAVI) has rapidly evolved over the past decade in response 
to growing population of older adults with aortic stenosis1. Initially, TAVI was approved for patients 
determined to be inoperable, but recently has expanded to those who were qualified as intermediate 
and low risk. The appropriate patient for a TAVI procedure typically has symptomatic senile degen-
erative AS of a trileaflet valve but recently indications for TAVI have expanded beyond typical and 
therefore choosing the optimal candidate has become more challenging. Patient selection for TAVI is 
based on accurate clinical and anatomical assessment of aortic stenosis. Patient selection is crucial 
when determining whether a patient is likely to benefit from catheter-based intervention as opposed 
to surgical intervention as well as determine whether patient is ill with the aortic stenosis or ill be-
cause of the aortic stenosis. This is because there are several clinical and anatomical aspects to be 
considered by the Heart team that favors a particular approach to treating severe aortic valve disease. 
The Heart team needs to discuss and evaluate expected quality of life versus risk of complications2. 
Besides of proper patient selection, the safety and efficacy of prothesis implantation depends on proce-
dural guidance which is based on a multimodality imaging approach. There are several patient factors 
and comorbidities which are associated with a poor post-TAVI outcome. These comorbidities include 
respiratory conditions associated with chronic lung disease, chronic kidney disease as well as frailty. 
Mobility, nutrition, and cognition in patients have been incorporated into many preoperative evalua-
tions for selecting TAVI patients due to the relationship with poorer outcomes. Identifying the comor-
bidities which lead to poor outcomes post-TAVI remains a particularly challenging issue. Larger trials 
are required to determine which subpopulations of patients stand to benefit most from this procedure.
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